72%* drop from November peak. See my chart a few posts above.
The kicker is TRIP is down again to $0.30 overnight, so it will have to gain a massive 250% to be a CPH equivalent of $0.30 once the merger happens. It's apparent the last of the CPH holders don't have their math skills up to scratch, gonna be a lonnnnng time before any (if any, I should say) substantial gains that you look for in a micro spec stock.
Creso Pharma (ASX:CPH) welcomes the Royal Commission and clinical studies on psilocybin, page-52
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)